Suzanne Ryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suzanne Ryan has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Davies
School of Medicine, Trinity College Dublin, Dublin, Ireland
1 shared publication - Shauna Munir
Our Lady’s Hospice & Care Services (Community Palliative Care), Dublin, Ireland
1 shared publication
Latest Publications
- 24 November 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (12) , 1124
Pharmacological interventions for sleep disturbance (“insomnia”) in patients with advanced cancer receiving specialist palliative care: a scoping review
Purpose Sleep disturbance (“insomnia”) is common in patients with advanced cancer receiving specialist palliative care. The aim of this scoping review was to determine the evidence for the various pharmacological interventions utilised for sleep disturbance in this cohort of patients. Methods Standard scoping review methodology was employed, and four databases were searched from inception (Medline, CINAHL, Embase, and the Cochrane Library). Hand searching of relevant sources was also undertaken. The search excluded non-English publications, and studies involving herbal remedies, and “complementary therapies”. Results Ten studies met the criteria for inclusion. The studies involved benzodiazepines (n = 5), “Z-drugs” (n = 2), melatonin (n = 2), antidepressants (n = 1), antipsychotics (n = 2), and dual orexin receptor antagonists (n = 1). Only three studies were randomised controlled trials, and only five of the studies used validated sleep assessment tools. The studies were mostly small in size (median – 47 patients). Conclusions This scoping review highlights that the evidence to support pharmacological interventions for sleep disturbance in patients with advanced cancer receiving specialist palliative care is extremely limited. Further research is required not only to assess efficacy, but also tolerability, given the side effect profile of these drugs (and the frailty of the patients).
- 24 November 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (12) , 1124
Pharmacological interventions for sleep disturbance (“insomnia”) in patients with advanced cancer receiving specialist palliative care: a scoping review
Purpose Sleep disturbance (“insomnia”) is common in patients with advanced cancer receiving specialist palliative care. The aim of this scoping review was to determine the evidence for the various pharmacological interventions utilised for sleep disturbance in this cohort of patients. Methods Standard scoping review methodology was employed, and four databases were searched from inception (Medline, CINAHL, Embase, and the Cochrane Library). Hand searching of relevant sources was also undertaken. The search excluded non-English publications, and studies involving herbal remedies, and “complementary therapies”. Results Ten studies met the criteria for inclusion. The studies involved benzodiazepines (n = 5), “Z-drugs” (n = 2), melatonin (n = 2), antidepressants (n = 1), antipsychotics (n = 2), and dual orexin receptor antagonists (n = 1). Only three studies were randomised controlled trials, and only five of the studies used validated sleep assessment tools. The studies were mostly small in size (median – 47 patients). Conclusions This scoping review highlights that the evidence to support pharmacological interventions for sleep disturbance in patients with advanced cancer receiving specialist palliative care is extremely limited. Further research is required not only to assess efficacy, but also tolerability, given the side effect profile of these drugs (and the frailty of the patients).